Targeting hyperoxaluria
at its source.

Hyperoxaluria is a condition of excess oxalate in the urine that can lead to kidney stone formation and renal disease. Orfan aims to change that by developing therapies that reduce oxalate production.

February 28 is International Rare Disease Day

#ShowYourRare